Open Access
| Issue |
BIO Web Conf.
Volume 174, 2025
2025 7th International Conference on Biotechnology and Biomedicine (ICBB 2025)
|
|
|---|---|---|
| Article Number | 01008 | |
| Number of page(s) | 5 | |
| Section | Advances in Molecular Biology and Genetic Research | |
| DOI | https://doi.org/10.1051/bioconf/202517401008 | |
| Published online | 12 May 2025 | |
- Hanami Y, Kumekawa M, Yamamoto T. Psoriasis vulgaris in a patient with antisynthetase syndrome. J Dermatol 48, e39-e40(2021). [CrossRef] [PubMed] [Google Scholar]
- Balogh, E. A., Bashyam, A. M., Ghamrawi, R. I. & Feldman, S. R. Emerging systemic drugs in the treatment of plaque psoriasis. Expert Opinion on Emerging Drugs 25, 89–100 (2020). [CrossRef] [PubMed] [Google Scholar]
- Griffiths, C. E. M. & Barker, J. N. W. N. Pathogenesis and clinical features of psoriasis. The Lancet 370, 263–271 (2007). [CrossRef] [Google Scholar]
- Ganguly, D. et al. Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8. Journal of Experimental Medicine 206, 1983–1994 (2009). [CrossRef] [PubMed] [Google Scholar]
- Kumar, V. & Sharma, A. Neutrophils: cinderella of innate immune system. International Immunopharmacology 10, 1325–1334 (2010). [CrossRef] [PubMed] [Google Scholar]
- Nestle, F. O., Kaplan, D. H. & Barker, J. Psoriasis. The New England Journal of Medicine 361, 496–509 (2009). [CrossRef] [PubMed] [Google Scholar]
- Capon, F., Trembath, R. C. & Barker, J. N. An update on the genetics of psoriasis. Dermatologic Clinics 22, 339–347 (2004). [CrossRef] [PubMed] [Google Scholar]
- Dascălu RC, Bărbulescu AL, Stoica LE, Dinescu ȘC, Biță CE, Popoviciu HV, Ionescu RA, Vreju FA. Review: A Contemporary, Multifaced Insight into Psoriasis Pathogenesis. J Pers Med. 14(5), 535(2024). [CrossRef] [Google Scholar]
- Temel, B., Adisen, E. & Gonen, S. HLA-Cw6 status and treatment responses between psoriasis patients. Indian Journal of Dermatology 66, 632-637 (2021). [CrossRef] [PubMed] [Google Scholar]
- Mak, R. K. H., Hundhausen, C. & Nestle, F. O. Progress in understanding the immunopathogenesis of psoriasis. Actas Dermo-Sifiliográficas 100, 2–13 (2009). [CrossRef] [Google Scholar]
- Fuentes-Duculan, J. et al. Autoantigens ADAMTSL5 and LL37 are significantly upregulated in active psoriasis and localized with keratinocytes, dendritic cells and other leukocytes. Experimental Dermatology 26, 1075–1082 (2017). [CrossRef] [PubMed] [Google Scholar]
- Heidenreich, R., Rocken, M. & Ghoreschi, K. Angiogenesis drives psoriasis pathogenesis. International Journal of Experimental Pathology 90, 232–248 (2009). [CrossRef] [PubMed] [Google Scholar]
- Luengas-Martinez, A., Hardman-Smart, J., Paus, R. & Young, H. S. Vascular endothelial growth factor-A as a promising therapeutic target for the management of psoriasis. Experimental Dermatology 29, 687–698 (2020). [CrossRef] [PubMed] [Google Scholar]
- Kato, Y. & Yamamoto, T. Dramatic effect of sunitinib with rapid but transient improvement for psoriasis in a patient with metastatic renal carcinoma. Journal of Dermatology 40, 1069–1070 (2013). [CrossRef] [PubMed] [Google Scholar]
- Pukale SS, Mittal A, Chitkara D. Topical Application of Vitamin D3-Loaded Hybrid Nanosystem to Offset Imiquimod-Induced Psoriasis. AAPS PharmSciTech 22(7), 238(2021). [CrossRef] [PubMed] [Google Scholar]
- Szymański Ł, Skopek R, Palusińska M, Schenk T, Stengel S, Lewicki S, Kraj L, Kamiński P, Zelent A. Retinoic Acid and Its Derivatives in Skin. Cells 9(12), 2660(2020). [CrossRef] [PubMed] [Google Scholar]
- Kurz B, Berneburg M, Bäumler W, Karrer S. Phototherapy: Theory and practice. J Dtsch Dermatol Ges. 21(8), 882-897(2023). [Google Scholar]
- Armstrong AW, Read C. Pathophysiology, Clinical Presentation, and Treatment of Psoriasis: A Review. JAMA 323(19), 1945-1960(2020). [CrossRef] [PubMed] [Google Scholar]
- Leone GM, Mangano K, Petralia MC, Nicoletti F, Fagone P. Past, Present and (Foreseeable) Future of Biological Anti-TNF Alpha Therapy. J Clin Med. 12(4), 1630(2023). [CrossRef] [Google Scholar]
- Yiu ZZN, Becher G, Kirby B, Laws P, Reynolds NJ, Smith CH, Warren RB, Griffiths CEM; BADBIR Study Group. Drug Survival Associated with Effectiveness and Safety of Treatment with Guselkumab, Ixekizumab, Secukinumab, Ustekinumab, and Adalimumab in Patients with Psoriasis. JAMA Dermatol. 158(10), 1131-1141(2022). [CrossRef] [PubMed] [Google Scholar]
- Bai, F. et al. Short-term efficacy and safety of IL-17, IL-12/23, and IL-23 inhibitors brodalumab, secukinumab, ixekizumab, ustekinumab, guselkumab, tildrakizumab, and risankizumab for the treatment of moderate to severe plaque psoriasis: a systematic review and network meta-analysis of randomized controlled trials. Journal of Immunology Research 2019, 1–25 (2019). [Google Scholar]
- Wang, W. M. & Jin, H. Z. Biologics in the treatment of pustular psoriasis. Expert Opinion on Drug Safety 19, 969–979 (2020). [CrossRef] [PubMed] [Google Scholar]
- Baum, P. et al. Pustular psoriasis: molecular pathways and effects of spesolimab in generalized pustular psoriasis. Journal of Allergy and Clinical Immunology 149, 1402–1412 (2022). [CrossRef] [Google Scholar]
- Zhao Guomin. Investigation of Anxiety and Emotional Reactions in Social Interactions of Psoriasis Patients [J]. Chinese Journal of Dermatology and Venereology of Integrated Traditional and Western Medicine. (3): 55-56. [Google Scholar]
- Nihal, Kundakçi, and, et al. The depression, anxiety, life satisfaction and affective expression levels in psoriasis patients[J]. [Google Scholar]
- Hayes, J., J. Koo. Psoriasis: depression, anxiety, smoking, and drinking habits[J]. Dermatologic Therapy. 23(2): 174-180. [Google Scholar]
- Wang Yuanfang. The Impact of Nursing Interventions on Anxiety and Depression in Psoriasis Patients [J]. Journal of Hainan Medical University. 2008. 14(2): 188-189. [Google Scholar]
- Schaaf, H., C. Eipp, R. Deubner, et al. [Psychosocial aspects of coping with tinnitus and psoriasis patients. A comparative study of suicidal tendencies, anxiety and depression] [J]. Hno. 2009. 57(1): 57-63. [CrossRef] [PubMed] [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.